Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Advanced Breast Cancer 1

Interventions

pembrolizumab 130Carboplatin 106Paclitaxel 65Cisplatin 61Gemcitabine 59Pemetrexed 57Bevacizumab 54Docetaxel 49Fluorouracil 43Oxaliplatin 41atezolizumab 37Dexamethasone 36Leucovorin 34Cetuximab 33130-nm albumin-bound paclitaxel 33Nivolumab 30Cyclophosphamide 30Prednisone 29Rituximab 28Capecitabine 28durvalumab 27Fulvestrant 24Lenalidomide 22enzalutamide 21Letrozole 21Irinotecan 21venetoclax 20Doxorubicin 19ribociclib 18pomalidomide 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Ritonavir × 30 days × Clear all
NCT06710990 2026-06-04

Investigation of Drug-drug Interaction of Ritonavir and Itraconazole on the Pharmacokinetics of SHR-A1811 in Subjects With HER2-expressing Advanced Breast Cancer

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Completed
17 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡